Prognostic significance of p53 and p63 immunolocalisation in primary and matched lymph node metastasis in oral squamous cell carcinoma

Acta Histochemica

Volumn 109, Issue 5, 2007, Pages 388-396

  Oliveira, Lucinei Roberto ^a   Ribeiro Silva, Alfredo ^a   Zucoloto, Sérgio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Immunohistochemistry; Oral cancer; p53; p63; Squamous cell carcinoma; Survival

Indexed keywords

CELLS; HISTOLOGY; STATISTICAL METHODS; TUMORS;

IMMUNOHISTOCHEMISTRY; ORAL CANCER; P53; SQUAMOUS CELL CARCINOMA;

IMMUNOLOGY;

PROTEIN P53; PROTEIN P63;

ADULT; ANTIBODY LABELING; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; LYMPH NODE METASTASIS; MALE; MOUTH CANCER; ORAL BIOPSY; ORAL SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PHENOTYPE; PROGNOSIS;

EID: 34848914795     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2007.03.006     Document Type: Article

References (47)

1. Ahomadegbe J.C., Barrois M., Fogel S., Le Bihan M.L., Douc-Rasy S., Duvillard P., et al. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene 10 (1995) 1217-1227
2. Aksu G., Karadeniz A., Saynak M., Fayda M., Kadehci Z., and Kocaelli H. Treatment results and prognostic factors in oral tongue cancer: analysis of 80 patients. Int J Oral Maxillofac Surg 35 (2006) 506-513
3. Association of Directors of Anatomic and Surgical Pathology. Recommendations for the reporting of specimens containing oral cavity and oropharynx neoplasms. Virchows Arch 437 (2000) 345-347
4. Bortoluzzi M.C., Yurgel L.S., Dekker N.P., Jordan R.C., and Regezi J.A. Assessment of p63 expression in oral squamous cell carcinomas and dysplasias. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 (2004) 698-704
5. Burns J.E., McFarlane R., Clark L.J., Mitchell R., Robertson G., Soutar D., et al. Maintenance of identical p53 mutations throughout progression of squamous cell carcinomas of the tongue. Eur J Cancer B Oral Oncol 30B (1994) 335-337
6. Califano J., van der Riet P., Westra W., Nawroz H., Clayman G., Piantadosi S., et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56 (1996) 2488-2492
7. Choi H.R., Batsakis J.G., Zhan F., Sturgis E., Luna M.A., and El-Naggar A.K. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Hum Pathol 33 (2002) 158-164
8. Danilewicz M., Sikorska B., and Wagrowska-Danilewicz M. Prognostic significance of the immunoexpression of matrix metalloproteinase MMP2 and its inhibitor TIMP2 in laryngeal cancer. Med Sci Monit 9 (2003) MT42-MT47
9. De Vicente J.C., Junqueira L.M., Zapatero A.H., Forcelledo M.F., Hernández-Vallejo G., and Arranz J.S. Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases. Head Neck 26 (2004) 22-30
10. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
11. Foschini M.P., Gaiba A., Cocchi R., Pennesi M.G., Gatto M.R., Frezza G.P., et al. Pattern of p63 expression in squamous cell carcinoma of the oral cavity. Virchows Arch 444 (2004) 332-339
12. Hall P.A., Campbell S.J., O'neill M., et al. Expression of the p53 homologue p63alpha and deltaNp63alpha in normal and neoplastic cells. Carcinogenesis 21 (2000) 153-160
13. Hasebe T., Mukai K., Yamaguchi N., Ishihara K., Kaneko A., Takasaki Y., et al. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter. Mod Pathol 7 (1994) 37-43
14. Hiratsuka H., Miyakawa A., Nakamori K., Kido Y., Sunakawa H., and Kohama G. Multivariate analysis of occult lymph node metastasis as a prognostic indicator for patients with squamous cell carcinoma of the oral cavity. Cancer 80 (1997) 351-356
15. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J.C., Valent A., et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90 (1997) 809-819
16. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
17. Koga F., Kawakami S., Fujii Y., Saito K., Ohtsuka Y., Iwai A., et al. Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin Cancer Res 9 (2003) 5501-5507
18. Kropveld A., Van Mansfeld A.D., Nabben N., Hordijk G.J., and Slootweg P.J. Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients. Eur J Cancer B Oral Oncol 32B (1996) 388-393
19. Lane D.P., and Benchimol S. p53: oncogene or anti-oncogene?. Genes Dev 4 (1990) 1-8
20. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
21. Lo Muzio L., Santarelli A., Caltabiano R., Rubini C., Pieramici T., Trevisiol L., et al. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma. Hum Pathol 36 (2005) 187-194
22. Moll U.M., Erster S., and Zaika A. p53, p63 and p73-solos, alliances and feuds among family members. Biochim Biophys Acta 1552 (2001) 47-59
23. Nakayama A., Ogawa A., Fukuta Y., and Kudo K. Relation between lymphatic vessel diameter and clinicopathologic parameters in squamous cell carcinomas of the oral region. Cancer 86 (1999) 200-206
24. Noone R.B., Bonner Jr. H., Raymond S., Brown A.S., Graham 3rd W.P., and Lehr H.B. Lymph node metastasis in oral carcinoma. A correlation of histopathology with survival. Plast Reconstr Surg 53 (1974) 158-166
25. Nylander K., Dabelsteen E., and Hall P.A. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 29 (2000) 413-425
26. Okada Y., Mataga I., Katagiri M., and Ishii K. An analysis of cervical lymph nodes metastasis in oral squamous cell carcinoma. Relationship between grade of histopathological malignancy and lymph nodes metastasis. Int J Oral Maxillofac Surg 32 (2003) 284-288
27. Ord R.A. Discussion. Primary oral squamous cell carcinoma: a review of 92 cases. J Oral Maxillofac Surg 54 (1996) 955
28. Peller S., Halevy A., Slutzki S., Kopilova Y., and Rotter V. p53 mutations in matched primary and metastatic human tumors. Mol Carcinog 13 (1995) 166-172
29. Ribeiro-Silva A., Ramalho L.N.Z., Garcia S.B., Brandão D.F., Chahud F., and Zucoloto S. p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer. Histopathology 47 (2005) 458-466
30. Sakai E., and Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene 7 (1992) 927-933
31. Shah J.P., Candela F.C., and Poddar A.K. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer 66 (1990) 109-113
32. Sheikh M.S., and Fornace Jr. A.J. Role of p53 family members in apoptosis. J Cell Physiol 182 (2000) 171-181
33. Siegelmann-Danieli N., Ben-Izhack O., Hanlon A., Ridge J.A., Stein M.E., Khandelwal V., et al. p53 alteration in oral tongue cancer is not significantly associated with age at diagnosis or tobacco exposure. Tumori 91 (2005) 346-350
34. In: Silverman Jr. S. (Ed). Oral cancer (1998), B.C. Decker Inc., Hamilton, Canada
35. Smiraglia D.J., Smith L.T., Lang J.C., Rush L.J., Dai Z., Schuller D.E., et al. Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC). J Med Genet 40 (2003) 25-33
36. Sobin L.H., and Wittekind C.H. TNM classification of malignant tumors (1997), Wiley-Liss, New York
37. Somers K.D., Merrick M.A., Lopez M.E., Incognito L.S., Schechter G.L., and Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res 52 (1992) 5997-6000
38. Takahashi Y., Noguchi T., Takeno S., Kimura Y., Okubo M., and Kawahara K. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma. Oncol Rep 15 (2006) 323-328
39. Takes R.P., Baatenburg De Jong R.J., Schuuring E., Litvinov S.V., Hermans J., and Van Krieken J.H. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell. Anticancer Res 18 (1998) 4793-4800
40. Tjebbes G.W., Leppers Vd Straat F.G., Tilanus M.G., Hordijk G.J., and Slootweg P.J. p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases. Oral Oncol 35 (1999) 384-389
41. Tsujita-Kyutoku M., Kiuchi K., Danbara N., Yuri T., Senzaki H., and Tsubura A. p63 expression in normal human epidermis and epidermal appendages and their tumors. J Cutan Pathol 30 (2003) 11-17
42. Urist M.J., Di Como C.J., Lu M.L., Charytonowicz E., Verbel D., Crum C.P., et al. Loss of p63 expression is associated with tumor progression in bladder cancer. Am J Pathol 161 (2002) 1199-1206
43. Wahi P.N., Cohen B., Luthra U.K., and Torloni H. Histological considerations. In: Wahi P.N., Cohen B., Luthra U.K., and Torloni H. (Eds). Histological typing of oral and oropharyngeal tumors (1977), World Health Organization, Geneva 15-19
44. Weber A., Bellmann U., Bootz F., Wittekind C., and Tannapfel A. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck. Int J Cancer 99 (2002) 22-28
45. Woolgar J.A. Histological distribution of cervical lymph node metastases from intraoral/oropharyngeal squamous cell carcinomas. Br J Oral Maxillofac Surg 37 (1999) 175-180
46. Yang A., Kaghad M., Wang Y., Gillett E., Fleming M.D., Dotsch V., et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2 (1998) 305-316
47. Zigeuner R., Tsybrovskyy O., Ratschek M., Rehak P., Lipsky K., and Langner C. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma. Urology 63 (2004) 1079-1083